LncRNA versican (VCAN)-AS1 promotes breast cancer cell migration, invasion, and EMT by working as a competing endogenous RNA to inhibit miR-106a-5p, which cancer cell progression via targeting signal transducer and activator of transcription 3 (STAT3) and inhibiting the STAT3/HIF1α axis (52). Here, VCAN is linked to breast cancer.